Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.525 USD | -2.80% | -0.40% | +92.31% |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 | CI |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Management Changes | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 35.88M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -27M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.93
x | P/E ratio 2025 * |
-1.44
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.2% |
Latest transcript on Brainstorm Cell Therapeutics Inc.
1 day | -2.80% | ||
1 week | -0.40% | ||
Current month | -7.03% | ||
1 month | -19.85% | ||
3 months | +63.55% | ||
6 months | +212.69% | ||
Current year | +92.31% |
Managers | Title | Age | Since |
---|---|---|---|
Chaim Lebovits
CEO | Chief Executive Officer | 53 | 07-06-30 |
Alla Patlis
DFI | Director of Finance/CFO | 37 | 12-12-22 |
Chief Tech/Sci/R&D Officer | - | 22-05-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Irit Arbel
FOU | Founder | 64 | 00-09-21 |
Uri Yablonka
BRD | Director/Board Member | 47 | 14-06-05 |
Jacob Frenkel
CHM | Chairman | 81 | 20-03-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 0.5401 | +1.52% | 367,454 |
24-04-19 | 0.532 | +3.44% | 1,007,163 |
24-04-18 | 0.5143 | -4.90% | 1,080,653 |
24-04-17 | 0.5408 | +2.60% | 528,799 |
24-04-16 | 0.5271 | -3.94% | 628,134 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+92.31% | 36.91M | |
+3.13% | 42.11B | |
+48.83% | 40.08B | |
+8.49% | 40B | |
-10.82% | 26.87B | |
+8.26% | 24.58B | |
-23.69% | 18.44B | |
+1.58% | 11.94B | |
+32.83% | 11.66B | |
+6.63% | 11.01B |
- Stock Market
- Equities
- BCLI Stock